5 takeaways from the abortion pill case before the U.S. Supreme Court

U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans’ access to the abortion pill mifepristone, in a case that could have sweeping implications for how the federal government approves scores of medications. The justices asked detailed questions about the safety of mifepristone, one of the most common ways for women in America to end a pregnancy. But they also raised issues with the arguments made by plaintiffs, a group of anti-abortion doctors, who want to see the drug’s availability severely restricted. Justices seemed concerned that the doctors were not reasonably impacted by how the drug is regulated.